Insiders / Arie Belldegrun, M.D.
Arie Belldegrun, M.D.
CIK 1296549personinsiderbeneficial owner
Companies
2
First seen
Feb 4, 2026
Last activity
Aug 7, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Allogene Therapeutics, Inc. · ALLO | — | — |
| UroGen Pharma Ltd. · URGN | — | — |
All securities held
3 positions · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| Allogene Therapeutics, Inc. | Stock Option (Right to buy)Derivative | 929,913 |
| Allogene Therapeutics, Inc. | Restricted Stock UnitDerivative | 263,033 |
| UroGen Pharma Ltd. | Stock Option (right ot buy)Derivative | 20,000 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Grant | URGN UroGen Pharma Ltd. Stock Option (right ot buy) | — | +20K | 20,000 0.04% of shares | low |
| Feb 2, 2026 | Grant | ALLO Allogene Therapeutics, Inc. Restricted Stock Unit | — | +263K | 263,033 0.08% of shares | low |
| Feb 2, 2026 | Grant | ALLO Allogene Therapeutics, Inc. Stock Option (Right to buy) | — | +930K | 929,913 0.27% of shares | low |